In vivo studies on insulin permeability of an immunoisolation device intended for islet transplantation using the microdialysis technique.
In this study, insulin was injected into Theracyte immunoisolation devices to analyze changes in the permeability of the device over time after implantation. The recovery of insulin was studied after subcutaneous implantation of the devices in rats, using the microdialysis technique. The area under the insulin concentration vs. time curves (AUC) after insulin injection in devices implanted 1 day previously did not differ significantly from the AUC after subcutaneous injection. At 1, 2 and 4 weeks after implantation, the recovery of insulin was significantly reduced, but at 3 months, the AUC was not significantly different from that in the control group. Histological examination showed that the number of vascular profiles within 15 microm of the device were significantly higher at 2, 4 weeks and 3 months after transplantation when compared to numbers at 1 week. The design of the device allows transplantation of cells at a chosen time point after its implantation. Delayed filling of the device would allow neovascularization of the device surface before graft implantation and we suggest that such a schedule might improve function of the encapsulated graft.
Rafael
E
E
Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden. Ehab.Rafael@karo.ki.se
Wernerson
A
A
Arner
P
P
Tibell
A
A
D000818:Animals; D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects; D015194:Diffusion Chambers, Culture / Q000295:instrumentation*; D005355:Fibrosis / Q000473:pathology; D020007:Implants, Experimental; D007328:Insulin / Q000097:blood / Q000493:pharmacokinetics*; D016381:Islets of Langerhans Transplantation / Q000295:instrumentation*; D008297:Male; D017551:Microdialysis; D018919:Neovascularization, Physiologic; D010539:Permeability; D051381:Rats; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin